<DOC>
	<DOCNO>NCT01299870</DOCNO>
	<brief_summary>Epilepsy disorder brain . The brain full `` nerve '' cell . Nerve cell normal electrical activity control many function body . Sometimes nerve cell function normally due many different reason disease , injury brain n't develop normally birth . When nerve cell function normally electrical activity control thing like muscle body movement get mixed cause seizure . When seizure occur , sometimes person lose control body movement , and/or bodily function . When seizure occur , person may become unconscious , and/or sens may affect . Seizures occur time , without warn , lead many health problem . `` Catamenial epilepsy '' specific form epilepsy woman . It closely related menstrual cycle . In form epilepsy seizures increase around menstrual period . By study , researcher hope learn whether Keishibukuryogan add-on therapy antiepileptic drug safe woman epilepsy .</brief_summary>
	<brief_title>Catamenial Epilepsy Treatment</brief_title>
	<detailed_description>It known female hormone level epilepsy patient different healthy woman . These hormonal difference may part cause catamenial epilepsy . It estimate least 1 every 3 woman epilepsy catamenial epilepsy . Although many antiepileptic drug available , difficult control seizure . In past , study use antiepileptic drug hormonal agent do treat catamenial epilepsy . However , medication work well cause side effect . Keishibukuryogan traditional Japanese herbal medication . It make 5 natural herb ( cinnamon bark , hoelen , moutan bark , peony root , peach kernel ) . It use treat disorder woman like menopause menstrual cycle problem . This first study examine safety Keishibukuryogan woman epilepsy . As , Keishibukuryogan current antiepileptic drug ( ) give study . Keishibukuryogan dietary supplement United States . It buy without prescription . The safety efficacy Keishibukuryogan study epilepsy . However , use safely Japan Asian country year .</detailed_description>
	<mesh_term>Epilepsy</mesh_term>
	<criteria>Inclusion Criteria 1 . Female positive diagnosis epilepsy , 2 . Women epilepsy ( WWE ) patient seizure treat AEDs dosage change past 30 day , 3 . WWE patient regular menstrual period range 28 Â± 7 day . 4 . WWE patient age range 21 45 year old . 5 . WWE patient willing able give sign informed consent form eligible participate study . 6 . WWE agree use nonhormonal form contraception duration study . No hormonal IntraUterine Device allow duration study . 7 . Patients history cancer must remission least 5 year . Exclusion Criteria 1 . History status epilepticus last 12 month 2 . Current diagnosis polycystic ovary syndrome and/or endometriosis 3 . Pregnant breast feed 4 . Allergy ingredient KBG ( cinnamon , hoelen , moutan bark , peony root , peach kernel ) 5 . Patients receive warfarin and/or antiplatelet drug 6 . Severe cardiovascular , renal hepatic impairment ( i.e. , coronary heart disease , myocardial infarction , renal failure , hepatitis ) history diseases 7 . Any unstable disease ( e.g. , mental disease , infection , cancer ) 8 . Lab value screen phase show 1.5 time upper range normal 9 . Patients receive phenytoin exclude ( since potential interaction phenytoin peony root report )</criteria>
	<gender>Female</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>February 2012</verification_date>
</DOC>